Allegra 120 film-coated tablets 120 mg blister 10 pcs

Fexofenadine hydrochloride – the active ingredient of the drug is a non-sedating antihistamine from the group of specific H1 receptor antagonists. The effect of the drug on the elimination of symptoms of allergic rhinitis is manifested within 1 hour after administration and lasts 24 hours. The drug does not affect psychomotor functions and reaction speed, so when taking it, you can drive a car and perform work that requires concentration.

Symptomatic treatment of seasonal allergic rhinitis in adults and children over 12 years of age.

Hypersensitivity to fexofenadine hydrochloride or to other components of the drug.

Age up to 12 years due to lack of adequate data on safety and efficacy.

The drug should not be used in children under 12 years of age.

Pregnancy.

There are no adequate data from use in pregnant women. Limited animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/fetal development, parturition or postnatal development. Fexofenadine hydrochloride should not be used during pregnancy unless clearly necessary, when the expected benefit to the mother outweighs the potential risk to the fetus.

Breastfeeding.

Since fexofenadine passes into breast milk, the drug should not be used during breastfeeding.

The recommended dose of fexofenadine hydrochloride for adults and children over 12 years of age is 120 mg per day in one dose, i.e. one 120 mg tablet once a day.

Oral administration.

Active ingredient: fexofenadine hydrochloride 1 tablet contains fexofenadine hydrochloride 120 mg (equivalent to 112 mg of fexofenadine).

Excipients: microcrystalline cellulose, corn starch, croscarmellose sodium, magnesium stearate, hypromellose, povidone, titanium dioxide (E 171), colloidal silicon dioxide, macrogol 400, yellow iron oxide mixture (E 172) and pink iron oxide mixture (E 172).

Store at a temperature not exceeding 25 ° C. Keep out of the reach of children.